Wahed Invest LLC Biogen Inc. Transaction History

Wahed Invest LLC

$491 Million
Q2 2024

A detailed history of Wahed Invest LLC transactions in Biogen Inc. stock. As of the latest transaction made, Wahed Invest LLC holds 3,247 shares of BIIB stock, worth $635,210. This represents 0.15% of its overall portfolio holdings.

Number of Shares

3,247

Previous 2,741 18.46%

Holding current value

$635,210

Previous $591,000 27.24%

% of portfolio

0.15%

Previous 0.14%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $96,403 - $119,780	506 Added 18.46%	3,247 $752,000
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $71,238 - $89,950	336 Added 13.97%	2,741 $591,000
Q4 2023 Mar 11, 2024	SELL	$222.59 - $267.94 $417,133 - $502,119	-1,874 Reduced 43.8%	2,405 $622,000
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $449,631 - $541,238	2,020 Added 89.42%	4,279 $1.11 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $49,393 - $55,748	195 Added 9.45%	2,259 $580,000
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $59,178 - $68,382	215 Added 11.63%	2,064 $587,000
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $8,723 - $9,939	34 Added 1.87%	1,849 $514,000
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $37,613 - $45,701	149 Added 8.94%	1,815 $502,000
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $21,221 - $29,262	109 Added 7.0%	1,666 $445,000
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $30,944 - $36,798	-165 Reduced 9.58%	1,557 $318,000
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $5,425 - $6,835	-28 Reduced 1.6%	1,722 $363,000
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $391,860 - $503,597	1,750 New	1,750 $420,000

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wahed Invest LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wahed Invest LLC with notifications on news.

Account